title: A cell-permeant amiloride derivative induces caspase-independent, AIF-mediated programmed necrotic death of breast cancer cells.
abstract: Amiloride is a potassium-sparing diuretic that has been used as an anti-kaliuretic for the chronic management of hypertension and heart failure. Several studies have identified a potential anti-cancer role for amiloride, however the mechanisms underlying its anti-tumor effects remain to be fully delineated. Our group previously demonstrated that amiloride triggers caspase-independent cytotoxic cell death in human glioblastoma cell lines but not in primary astrocytes. To delineate the cellular mechanisms underlying amiloride's anti-cancer cytotoxicity, cell permeant and cell impermeant derivatives of amiloride were synthesized that exhibit markedly different potencies in cancer cell death assays. Here we compare the cytotoxicities of 5-benzylglycinyl amiloride (UCD38B) and its free acid 5-glycinyl amiloride (UCD74A) toward human breast cancer cells. UCD74A exhibits poor cell permeability and has very little cytotoxic activity, while UCD38B is cell permeant and induces the caspase-independent death of proliferating and non-proliferating breast cancer cells. UCD38B treatment of human breast cancer cells promotes autophagy reflected in LC3 conversion, and induces the dramatic swelling of the endoplasmic reticulum, however these events do not appear to be the cause of cell death. Surprisingly, UCD38B but not UCD74A induces efficient AIF translocation from the mitochondria to the nucleus, and AIF function is necessary for the efficient induction of cancer cell death. Our observations indicate that UCD38B induces programmed necrosis through AIF translocation, and suggest that its cytosolic accessibility may facilitate drug action.
authors: Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California, United States of America.
authors: Leonardo J
authors: LJ
authors: Leon
authors: Nagarekha
authors: N
authors: Pasupuleti
authors: Fredric
authors: F
authors: Gorin
authors: Kermit L
authors: KL
authors: Carraway
mesh_terms: D000584:Amiloride / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D017209:Apoptosis / Q000187:drug effects*; D051033:Apoptosis Inducing Factor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002154:Calpain / Q000378:metabolism; D020169:Caspases / Q000378:metabolism*; D002453:Cell Cycle / Q000187:drug effects; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D002463:Cell Membrane Permeability; D002467:Cell Nucleus / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000648:ultrastructure; D005260:Female; D005998:Glycine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity; D006801:Humans; D021381:Protein Transport
chemical_list: C584412:5-benzylglycinyl amiloride; D051033:Apoptosis Inducing Factor; D000584:Amiloride; D002154:Calpain; D020169:Caspases; D002118:Calcium; D005998:Glycine
references: Nat Rev Cancer. 2007 Nov;7(11):834-46
references: 17957189
references: Ann N Y Acad Sci. 2009 Aug;1171:2-11
references: 19723031
references: Sci Signal. 2011 Apr 05;4(167):ra20
references: 21467298
references: Biochem Cell Biol. 2009 Apr;87(2):401-14
references: 19370058
references: Chem Res Toxicol. 2009 Nov;22(11):1817-26
references: 19848398
references: Brain Res. 2010 Dec 2;1363:159-69
references: 20869350
references: Mol Cancer Res. 2008 Jun;6(6):965-77
references: 18567800
references: J Pharmacol Exp Ther. 2004 Jul;310(1):67-74
references: 15010500
references: Drug Resist Updat. 2007 Dec;10(6):235-55
references: 18180198
references: Toxicol Lett. 1999 Jun 1;106(2-3):215-28
references: 10403666
references: Oncologist. 2006 Apr;11(4):342-57
references: 16614230
references: Neuron. 2003 Oct 9;40(2):401-13
references: 14556717
references: Bioorg Med Chem Lett. 2012 Apr 1;22(7):2635-9
references: 22366654
references: Mol Cell Biol. 2007 Jul;27(13):4844-62
references: 17470554
references: Cancer Res. 2000 Dec 1;60(23):6601-6
references: 11118041
references: J Biol Chem. 2006 Nov 17;281(46):34870-9
references: 16990266
references: Cell Death Differ. 2005 Nov;12 Suppl 2:1509-18
references: 16247498
references: Cancer Lett. 2010 Sep 28;295(2):198-204
references: 20338684
references: J Gastroenterol Hepatol. 2011 Feb;26(2):364-70
references: 21261728
references: Ann N Y Acad Sci. 2000;926:1-12
references: 11193023
references: Science. 2004 Nov 5;306(5698):990-5
references: 15528435
references: Teratology. 1973 Jun;7(3):253-66
references: 4807128
references: Ann Oncol. 2006 Sep;17 Suppl 10:x315-24
references: 17018746
references: Anat Embryol (Berl). 1990;181(3):195-213
references: 2186664
references: J Neurochem. 2007 Dec;103(5):2004-14
references: 17760869
references: Curr Top Dev Biol. 2007;78:217-45
references: 17338918
references: Mol Cancer. 2011 Jun 06;10:69
references: 21639944
references: J Cell Biol. 2010 Feb 22;188(4):547-63
references: 20156964
references: J Pharmacol Exp Ther. 2005 Mar;312(3):961-7
references: 15509720
references: Blood. 2000 Feb 15;95(4):1427-34
references: 10666221
references: Clin Cancer Res. 2005 May 1;11(9):3155-62
references: 15867207
references: Int J Cancer. 2011 Nov 1;129(9):2051-61
references: 21544803
references: Mol Cancer Ther. 2007 May;6(5):1641-9
references: 17513612
references: IUBMB Life. 2011 Apr;63(4):221-32
references: 21438113
references: Curr Opin Cell Biol. 2010 Apr;22(2):263-8
references: 20045303